Holen Sie sich die Stockscreener-App
4.53
0.88%
-0.04
Vorhandelsmarkt:
4.65
0.12
+2.65%
Prime Medicine Inc Aktie (PRME) Neueste Nachrichten
What analysts say about Prime Medicine Inc. stockGame-changing capital returns - jammulinksnews.com
Prime Medicine Inc. Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com
Is Prime Medicine Inc. a good long term investmentPowerful market insights - jammulinksnews.com
What drives Prime Medicine Inc. stock priceExponential wealth increase - Autocar Professional
Prime Medicine(PRME) Shares Soar 10.65% on Analyst Rating, Funding Boost - AInvest
Prime Medicine Surges 18% on Funding Catalyst: Is This the Start of a Biotech Breakout? - AInvest
BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT - MSN
Prime Medicine stock price target reiterated at $6 by JMP on CF funding - Investing.com Canada
Prime Medicine (PRME.O) Surges 5.9%: What’s Behind the Intraday Rally? - AInvest
Prime Medicine (PRME): A High-Conviction Biotech Play with a 154% Upside - AInvest
10 Hot Penny Stocks to Invest in Now - Insider Monkey
Cystic Fibrosis Foundation grants new funding to advance development of Prime Medicine’s prime editors - BioWorld MedTech
Prime Medicine, Inc.: Buy Rating Affirmed on Innovative Gene Editing Technology and Strategic Advancements - TipRanks
Prime Medicine stock rating reiterated by H.C. Wainwright on CF partnership - Investing.com Canada
CF Trading Volume Surges 77% to 2.91 Billion, Ranks 364th in Market - AInvest
Prime Medicine Announces CSO Resignation and Transition - The Globe and Mail
Prime Editing's Billion-Dollar Gamble: Can Prime Medicine's $24M Boost Cement Dominance in Cystic Fibrosis? - AInvest
Prime Medicine announces additional funding of up to $24M from CF Foundation - TipRanks
Prime Medicine Announces Additional Funding of Up to $24 - GlobeNewswire
Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation - citybiz
Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy - Yahoo Finance
Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis - The Manila Times
Cystic Fibrosis Foundation expands funding for Prime Medicine By Investing.com - Investing.com Nigeria
Prime Medicine Secures Up to $24 Million from Cystic Fibrosis Foundation to Advance Prime Editing Technology for Cystic Fibrosis Treatment - Nasdaq
Cystic Fibrosis Foundation expands funding for Prime Medicine - Investing.com
CF Foundation Backs Prime Medicine with $24M to Develop Cure for 93% of Cystic Fibrosis Patients - Stock Titan
Prime Medicine chief scientific officer to depart, will serve as consultant - Investing.com Nigeria
Prime Medicine stock plummets amid restructuring and leadership changes - MSN
Prime Medicine soars as Jones sees it as an acquisition target - MSN
Prime Medicine's Liver Gene Therapy Platform: A Breakthrough in Rare Disease Treatment? - AInvest
Prime Medicine: Pressing Forward With Lead Liver Targeting Indications (NASDAQ:PRME) - Seeking Alpha
Prime Therapeutics stock surges 35% on JonesTrading's acquisition optimism. - AInvest
JonesResearch lists factors for Prime Medicine continued share rally - TipRanks
Prime Medicine stock soars amid gene editing sector momentum By Investing.com - Investing.com Canada
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):